Press Release | NeoGenomics Laboratories

April 11, 2022

NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D

April 8, 2022

NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022

March 17, 2022

NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung Cancer

March 2, 2022

NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences

February 23, 2022

NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021

February 14, 2022

NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer

February 11, 2022

NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma

February 8, 2022

NeoGenomics to Participate Virtually in Multiple Upcoming Institutional Investor Conferences

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients